126 related articles for article (PubMed ID: 28967274)
1. The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome
Jensen GM
J Liposome Res; 2017 Sep; 27(3):173-179. PubMed ID: 28967274
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
3. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
Azanza JR; Sádada B; Reis J
Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients.
Böhme A; Hoelzer D
Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.
Aversa F; Busca A; Candoni A; Cesaro S; Girmenia C; Luppi M; Nosari AM; Pagano L; Romani L; Rossi G; Venditti A; Novelli A
J Chemother; 2017 Jun; 29(3):131-143. PubMed ID: 28335692
[TBL] [Abstract][Full Text] [Related]
6. AmBisome today: expanding the perspectives on liposomal amphotericin B.
Richardson M
Acta Biomed; 2006; 77 Suppl 2():3-4. PubMed ID: 16918058
[No Abstract] [Full Text] [Related]
7. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
8. Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature.
Johnson MD; Drew RH; Perfect JR
Pharmacotherapy; 1998; 18(5):1053-61. PubMed ID: 9758315
[TBL] [Abstract][Full Text] [Related]
9. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis.
Antony S; Dominguez DC; Sotelo E
J Natl Med Assoc; 2003 Oct; 95(10):982-5. PubMed ID: 14620712
[TBL] [Abstract][Full Text] [Related]
10. Persistent acute tubular toxicity after switch from conventional amphotericin B to liposomal amphotericin B (Ambisome).
Gerbaud E; Tamion F; Girault C; Clabault K; Lepretre S; Leroy J; Bonmarchand G
J Antimicrob Chemother; 2003 Feb; 51(2):473-5. PubMed ID: 12562731
[No Abstract] [Full Text] [Related]
11. Liposomal amphotericin B therapy of murine histoplasmosis.
Graybill JR; Bocanegra R
Antimicrob Agents Chemother; 1995 Aug; 39(8):1885-7. PubMed ID: 7486941
[TBL] [Abstract][Full Text] [Related]
12. Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products.
Liu Y; Mei Z; Mei L; Tang J; Yuan W; Srinivasan S; Ackermann R; Schwendeman AS
Eur J Pharm Biopharm; 2020 Dec; 157():241-249. PubMed ID: 32980448
[TBL] [Abstract][Full Text] [Related]
13. Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B.
Bohm NM; Hoover KC; Wahlquist AE; Zhu Y; Velez JC
Antimicrob Agents Chemother; 2015 Nov; 59(11):6816-23. PubMed ID: 26282423
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B in critically ill paediatric patients.
Sideri G; Falagas ME; Grigoriou M; Vouloumanou EK; Papadatos JH; Lebessi E; Kafetzis DA
J Clin Pharm Ther; 2012 Jun; 37(3):291-5. PubMed ID: 21777406
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B--not so terrible.
Bishara J; Weinberger M; Lin AY; Pitlik S
Ann Pharmacother; 2001 Mar; 35(3):308-10. PubMed ID: 11261528
[TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK.
Bruynesteyn K; Gant V; McKenzie C; Pagliuca T; Poynton C; Kumar RN; Jansen JP
Eur J Haematol; 2007 Jun; 78(6):532-9. PubMed ID: 17419744
[TBL] [Abstract][Full Text] [Related]
18. Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital.
Ringdén O
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():51-5. PubMed ID: 11801582
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
Chakraborty KK; Naik SR
J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
